Tyrosine, phenylalanine, and tryptophan in gastroesophageal malignancy: A systematic review

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 1, 2015, Pages 32-38

  Wiggins, Tom ^a   Kumar, Sacheen ^a   Markar, Sheraz R ^a   Antonowicz, Stefan ^a   Hanna, George B ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC AMINO ACID; BIOLOGICAL MARKER; PHENYLALANINE; TRYPTOPHAN; TYROSINE;

BLOOD LEVEL; BODY FLUID; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; EARLY DIAGNOSIS; ESOPHAGUS CANCER; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH CONTENT; SYSTEMATIC REVIEW; URINE LEVEL; ESOPHAGEAL NEOPLASMS; METABOLISM; STOMACH NEOPLASMS;

ESOPHAGEAL NEOPLASMS; HUMANS; PHENYLALANINE; STOMACH NEOPLASMS; TRYPTOPHAN; TYROSINE;

EID: 84921059263     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0980     Document Type: Review

References (41)

1. CR UK. Cancer incidence for common cancers. Cancer Research UK; 2014 [last accessed 2014 Jun 5]. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/commoncancers.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
3. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-50.
4. Arvanitakis C, Nikopoulos A, Giannoulis E, Theoharidis A, Georgilas V, Fotiou H, et al. The impact of early or late diagnosis on patient survival in gastric cancer in Greece. Hepatogastroenterology 1992;39:355-7.
5. Miyamoto A, Kuriyama S, Nishino Y, Tsubono Y, Nakaya N, Ohmori K, et al. Lower risk of death from gastric cancer among participants of gastric cancer screening in Japan: a population-based cohort study. Prev Med 2007;44:12-9.
6. Liesenfeld DB, Habermann N, Owen RW, Scalbert A, Ulrich CM. Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiol Biomarkers Prev 2013;22:2182-201.
7. Lai H-S, Lee J-C, Lee P-H, Wang S-T, Chen W-J. Plasma free amino acid profile in cancer patients. Semin Cancer Biol 2005;15:267-76.
8. Bozzetti F, Migliavacca S, Scotti A, Bonalumi MG, Scarpa D, Baticci F, et al. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 1982;196:170-9.
9. Riccardi D, Allen K. Nutritional management of patients with esophageal and esophagogastric junction cancer. Cancer Control 1999;6:64-72.
10. Womack M, RoseW. Feeding experiments withmixtures of highly purified amino acids: VI The relation of pehnylalanine and tyrosine to growth. J Biol Chem 1934;107:449-58.
11. Lichter-Konecki U, Hipke C, Konecki D. Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Mol Genet Metab 1999;316:308-16.
12. Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-unterweger B, et al. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett 2008;272:141-7.
13. Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, Fuchs D. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 2008;35:303-7.
14. Kakihara Y, Ichihara K. Studies of phenol formation. I. Method of the determination of phenol and its microbial formation from tyrosine and tyrosine derivatives. Med J Osaka Univ 1953;3:497-507
15. Kumar S, Huang J, Abbassi-ghadi N, Patrik S, Smith D, Hanna GB. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem 2013;85:6121-8
16. Cheng Y, XieG, Chen T, Qiu Y. Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res 2011;11:1354-63.
17. Kumar S, Huang J, Cushnir J. Selected ion flow tube-MS analysis of headspace vapor from gastric content for the diagnosis of gastro-esophageal cancer. Anal Chem 2012;84:9550-7
18. Whiting P, Rutjes A. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern 2011;155:529-36.
19. Whiting P. Sources of variation and bias in studies of diagnostic accuracy. Ann Intern Med 2004;140:189-202.
20. Miyagi Y, Higashiyama M, Gochi A, Akaike M, Ishikawa T, Miura T, et al. Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLoS ONE 2011;6:e24143.
21. Zhang X, Xu L, Shen J, Cao B, Cheng T. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. Biochimica Biophys Acta 2013;1832:1207-16.
22. Norton JA, Gorschboth CM, Wesley RA, Burt ME, Brennan MF. Fasting plasma amino acid levels in cancer patients. Cancer 1985;56:1181-6.
23. Zhang J, Bowers J, Liu L, Wei S, Gowda GA, Hammoud Z, et al. Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS ONE 2012;7:e30181.
24. Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr 2012;26:548-58.
25. Deng K, Lin S, Zhou L, Geng Q, Li Y, Xu M, et al. Three aromatic amino acids in gastric juice as potential biomarkers for gastric malignancies. Anal Chim Acta 2011;694:100-7.
26. Deng K, Lin S, Zhou L, Li Y, Chen M, Wang Y, et al. High levels of aromatic amino acids in gastric juice during the early stages of gastric cancer progression. PLoS ONE 2012;7:e49434.
27. Abasov I. Chromatographic analysis of free amino acids of gastric juice in patients with cancer and other stomach diseases. J Gastroenterol 1969; 5:269-73.
28. Segawa K, Nakazawa S, Tsukamoto Y, Yamaguchi H, Goto H, Kurita Y. Amino acid patterns in human gastric juice in health and gastric disease. Jpn J Med 1985;24:244-9.
29. Hasim A, Ma H, Mamtimin B, Abudula A, Niyaz M, Zhang L-W, et al. Revealing the metabonomic variation of EC using 1H-NMR spectroscopy and its association with the clinicopathological characteristics. Mol Biol Rep 2012;39:8955-64.
30. Davis VW, Schiller DE, Eurich D, Sawyer MB. Urinary metabolomic signature of esophageal cancer and Barrett's esophagus. World J Surg Oncol 2012;10:271.
31. Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, et al. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. J Chromatogr B 2009;877:3111-7.
32. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flightmass spectrometry. Cancer Res 2009;69:4918-25.
33. Naini AB, Dickerson JW, Brown MM. Preoperative and postoperative levels of plasma protein and amino acid in esophageal and lung cancer patients. Cancer 1988;62:355-60.
34. Song H, Wang L, Liu H-L, Wu X-B, Wang H-S, Liu Z-H, et al. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol Rep 2011;26:431-8.
35. Lian W, Ma DJ, Xu X, Chen Y, Wu YL. Rapid high-performance liquid chromatography method for determination of tryptophan in gastric juice. J Dig Dis 2012;13:100-6.
36. Kawamura I, Moldawer LL, Keenan RA, Batist G, Bothe A, Bistrian BR, et al. Altered amino acid kinetics in rats with progressive tumor growth. Cancer Res 1982;42:824-9.
37. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009;121:29-40.
38. Kim CS, Cho S-H, Chun HS, Lee S-Y, Endou H, Kanai Y, et al. BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol Pharm Bull 2008;31:1096-100.
39. Engbring JA, Kleinman HK. The basement membrane matrix in malignancy. J Pathol 2003;200:465-70.
40. Seftor REB, Seftor EA, Koshikawa N, Meltzer PS, Gardner LMG, Bilban M, et al. Cooperative interactions of laminin 5 g 2 chain, matrix metalloproteinase-2, andmembrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61:6322-7.
41. Smith EA, Macfarlane GT. Enumeration of human colonic bacteria producing phenolic and indolic compounds: effects of pH, carbohydrate availability and retention time on dissimilatory aromatic amino acid metabolism. J Appl Bacteriol 1996;81:288-302.